Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$8.59 - $20.77 $191,617 - $463,316
-22,307 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $32,204 - $73,973
2,075 Added 10.26%
22,307 $422,000
Q4 2021

Feb 09, 2022

BUY
$28.89 - $35.33 $19,182 - $23,459
664 Added 3.39%
20,232 $710,000
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $34,982 - $42,124
981 Added 5.28%
19,568 $716,000
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $74,418 - $123,307
3,140 Added 20.33%
18,587 $730,000
Q1 2021

May 14, 2021

SELL
$27.01 - $36.8 $38,138 - $51,961
-1,412 Reduced 8.38%
15,447 $436,000
Q4 2020

Feb 16, 2021

BUY
$27.51 - $34.36 $34,525 - $43,121
1,255 Added 8.04%
16,859 $540,000
Q3 2020

Nov 12, 2020

BUY
$25.8 - $34.61 $402,583 - $540,054
15,604 New
15,604 $504,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.